Replicate Bioscience Presents Positive Data from Phase 1 Trial and Preclinical Data with Novel Self-Replicating RNA at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Positive data from Phase 1 trial of RBI-4000 vaccine achieve WHO-established surrogate…
